Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of KRX-0502 (Ferric Citrate) Dose Regimens in Subjects With Non-Dialysis Dependent Chronic Kidney Disease and Iron-Deficiency Anemia

NCT03236246 is registered in ClinicalTrials.gov with Keryx Biopharmaceuticals as lead sponsor.

NCT NCT03236246
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03236246 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of KRX-0502 (Ferric Citrate) Dose Regimens in Subjects With Non-Dialysis Dependent Chronic Kidney Disease and Iron-Deficiency Anemia
Lead sponsor
Keryx Biopharmaceuticals
Phase
Phase 4
Overall status
Completed
Start date
August 15, 2017
Completion date
September 27, 2019
Enrollment
206 (actual)
Sites
28

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney diseases, iron deficiency anemia